Home › Encyclopedia › Epithalon: Research Status, Identity, and Trial Data
Research / Unapproved

Epithalon: Research Status, Identity, and Trial Data

Molecular formulaC14H22N4O9
Molecular weight390.35 g/mol
Registered trials1
PubChem CID219042

Regulatory Status

Epithalon is classified as unapproved and is used only in research settings. There is no FDA-approved label, indication, or dosing guidance for this compound.

What Epithalon Is

Epithalon is a synthetic peptide with the molecular formula C14H22N4O9 and a molecular weight of 390.35. Its PubChem entry (CID 219042) defines its chemical structure, but no approved drug label exists to describe an indication or mechanism of action in humans.

Trial Footprint

One registered clinical trial currently references epithalon. That study, "Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks" (NCT07888595), is listed as early phase and is enrolling by invitation. This limited footprint reflects an early stage of clinical investigation rather than an established evidence base.

FAQ

Is epithalon FDA-approved?
No. Epithalon has no FDA-approved label, and there is no approved indication or dosing information for it. It is currently studied only in a research context.
What is epithalon chemically?
Epithalon is a synthetic peptide with the molecular formula C14H22N4O9 and a molecular weight of 390.35. Its structure is catalogued in PubChem under CID 219042.
How many clinical trials involve epithalon?
One clinical trial currently references epithalon in available registries. It is an early phase study that is enrolling participants by invitation.
What is the trial studying?
The listed trial, NCT07888595, is examining systemic and topical geroprotective effects using aging clock assessments (START and REST). It is in an early enrollment stage, so no outcome data are yet available.
Are there known side effects of epithalon?
No adverse event report data are currently available for epithalon. This reflects a lack of reported data rather than a confirmation of safety.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem CID 219042 ClinicalTrials.gov NCT07888595

Updated 2026-11-07